Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: A randomized, intraindividual comparison trial with 12-month follow-up

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 1, 2012, Pages 36-40

  Sotiriou, E ^a   Apalla, Z ^b   Chovarda, E ^a   Goussi, C ^a   Trigoni, A ^a   Ioannides, D ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b State Hospital for Skin and Venereal Diseases   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FACE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; ILLUMINATION; MALE; PERSONALIZED MEDICINE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SCALP; TREATMENT RESPONSE;

AGED; AMINOLEVULINIC ACID; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCALP;

EID: 83755206315     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04003.x     Document Type: Article

References (21)

1. Salasche SJ,. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42 (Suppl.): s4-s7. (Pubitemid 30481723)
2. Glogau R,. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-24.
3. Braathen IR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. J Am Acad Dearmatol 2007; 56: 125-143. (Pubitemid 44969292)
4. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-1266.
5. Star WM, van't Veen AJ, Robinson DJ, Munte K, de Haas ERM, Sterenborg HJCM,. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light-fractions with a two-hour interval: long-term follow-up. Acta DermVenereol 2006; 86: 412-417. (Pubitemid 44450096)
6. de Haas ERM, Kruijt B, Sterenborg HJCM, Neumann HAM, Robinson DJ,. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol 2006; 126: 2679-2686. (Pubitemid 44764052)
7. de Haas ERM, Sterenborg HJCM, Neumann HAM, Robinson DJ,. Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme. Arch Dermatol 2007; 143: 264-265. (Pubitemid 46294598)
8. De Haas ERM, de Vijlder HC, Sterenborg HJCM, et al. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melama skin cancer. JEADV 2008; 22: 426-430. (Pubitemid 351436911)
9. Sotiriou E, Apalla Z, Ioannides D,. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma. Photodermatol Photoimmunol Photomed 2009; 25: 331-332.
10. Robinson DJ, de Bruijn HS, Star WM, Sterenborg HJCM,. Dose and timing of the first light fraction in two fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem Photobiol 2003; 77: 319-323.
11. de Bruijn HS, van der Ploeg-van, Heuvel A, et al. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval. Photochem Photobiol B 2006; 85: 184-190. (Pubitemid 44567376)
12. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227-232. (Pubitemid 36232321)
13. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99-106. (Pubitemid 36648700)
14. Tarsted M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate in actinic keratosis of face and scalp. Acta Derm Venereol 2005; 85: 424-428. (Pubitemid 41345617)
15. de Bruijn HS, de Haas ERM, Hebeda KM, et al. Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin. Photochem Photobiol Sci 2007; 6: 1325-1331. (Pubitemid 350191107)
16. Thissen MR, de Blois MW, Robinson DJ, et al. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-ALA and repeated illumination. J Invest. Dermatol. 2002; 118: 239-245. (Pubitemid 34158476)
17. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-262.
18. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow-up. Br J Dermatol 2006; 155: 1262-1269. (Pubitemid 44730005)
19. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-1036. (Pubitemid 44564515)
20. Nakano A, Tamada Y, Watanabe D, et al. A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and listological severity. Photodermatol Photoimmunol Photomed 2009; 25: 37-40.
21. Puizina-Ivic N, Zorc H, Vanjaka-Rogosic L, et al. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Anthropol 2008; 32 (Suppl. 2): 67-73.